Recent Advances of Nanozymes as Therapies for ROS-Induced Diseases
DOI:
https://doi.org/10.62051/8xzp5k10Keywords:
Nanozymes, therapeutics, inflammation, ROS -related diseases.Abstract
Recently nanozymes have received more and more attention and have been applied in many fields. Recent advances of applications of nanozymes as therapies for various reactive oxygen species (ROS)-induced diseases are summarized in this account. For each case, the rational design strategies as well as various factors regulating the multiple enzyme-like activities, are also discussed. Perspectives and Challenges are also mentioned.
Downloads
References
[1] a) Mao M, Guan X, Wu F and Ma L 2022 Nanomaterials 12 638; b) Chen Y, Chen T, Wu X and Yang G 2019 Sens. Actuators B 279 374; c) Wang Z, Wu J, Zheng J, Shen X, Yan L, Wei H, Gao X and Zhao Y 2021, Nat. Commun. 12 6866; d) Song C, Liu H, Zhang L, Wang J, Zhao C, Xu Q and Yao C 2022 Sens. Actuators B 353 131131
[2] Bhagat S, Srikanth V N V, Shutthanandan V, Bowden M, Karakoti A S and Singh S 2018 J. Colloid Interface Sci. 222 701
[3] a) Tian R, Ma H, Ye W, Li Y, Wang S, Zhang Z, Liu S, Zang M, Hou J, Xu J, Lu Q, Sun H, Ba F, Yang Y and Liu J 2022 Adv. Funct. Mater. 32 2204025; b) Ali A, Ovais M, Zhou H, Rui Y and Chen C 2021 Biomaterials 275 120951
[4] Sheng J, Wu Y, Ding H, Feng K, Shen Y, Zhang Y and Gu N 2024 Adv. Mater. 36 2211210
[5] a) Yang B, Chen Y and Shi J 2019 Chem. Rev. 119 4881; b) Yang B, Chen Y, Shi J, 2019 Adv. Mater. 31 1901778
[6] Zhao S, Li Y, Liu Q, Li S, Cheng Y, Cheng C, Sun Z, Du Y, Butch C J and Wei H 2020 Adv. Funct. Mater. 30 2004692
[7] Muhammad F, Huang F, Cheng Y, Chen X, Wang Q, Zhu C, Zhang Y, Yang X, Wang P and Wei H 2022 ACS Nano 16 20567
[8] Wang Q, Cheng C, Zhao S, Liu Q, Zhang Y, Liu W, Zhao X, Zhang H, Pu J, Zhang S, Zhang H, Du Y and Wei H 2022 Angew. Chem. Int. Ed. 61 e202201101
[9] Zhang C, Wang H, Yang X, Fu Z, Ji X, Shi Y, ZHONG J , Hu W , YE Y, Wang Z and Ni D 2022 Sci. Adv. 8 eabp9882
[10] Hou L, Gong F, Liu B, Yang X, Chen L, Li G, Gong Y, Liang C, Yang N, Shen X, Liu Z and Cheng L 2022 Theranostics 12 3834
[11] Yu Y, Zhao X, Xu X, Cai C, Tang X, Zhang Q, Zhong L, Zhou F, Yang D and Zhu Z 2023 Adv. Mater. 35 2304967
[12] Selman M, King T and Pardo A 2001 Ann Intern Med. 134 136
[13] Hassan A I, Samir A, Youssef H F, Mohamed S S, Asker M S and Mahmoud M G 2021 J. Pharm. Pharmacol. 73 1503
[14] Krusic P J, Wasserman E, Keizer P N, Morton J R and Preston K F 1991 Science 254 1183
[15] Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson S R and Moussa F 2005 Nano Lett. 5 2578
[16] Dong R, Liu, M, Huang X, Liu Z, Jiang D, Xiao H and Dai H 2020 Int. J. Nanomedicine 15 2269
[17] Liu Q, Ren Y, Jia H, Yuan H, Tong Y, Sumasri K, Mao X, Huang Y, Chen C, Zheng Z, Wang L and He W 2023 ACS Nano 17 22527
[18] Liu Y, Mao Y, Xu E, Jia H, Zhang S, Dawson V L, Dawson T M, Li Y, Zheng Z, He W and Mao X 2021 Nano Today 36 101027
[19] Jia Z, Yuan X, Wei J, Guo X, Gong Y, Li J, Zhou H, Zhang L and Liu J 2021 ACS Appl. Mater. Interf. 13 49602
Downloads
Published
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
